Clarmin Explorations Inc. Stock Toronto S.E.
Equities
CYBN
CA23256X1006
Biotechnology & Medical Research
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 364M 266M |
---|---|---|---|---|---|
Net income 2024 * | -74M -54.09M | Net income 2025 * | -65M -47.52M | EV / Sales 2024 * | - |
Net cash position 2024 * | 170M 125M | Net cash position 2025 * | 126M 91.96M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-2.03
x | P/E ratio 2025 * |
-3.27
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 93.34% |
Latest transcript on Clarmin Explorations Inc.
Managers | Title | Age | Since |
---|---|---|---|
Douglas Drysdale
CEO | Chief Executive Officer | 54 | 20-07-31 |
Paul Glavine
FOU | Founder | 35 | 16-10-12 |
Eric So
FOU | Founder | 49 | 16-10-12 |
Members of the board | Title | Age | Since |
---|---|---|---|
Eric So
FOU | Founder | 49 | 16-10-12 |
Mark Lawson
BRD | Director/Board Member | 52 | 20-11-04 |
Grant Froese
BRD | Director/Board Member | 62 | 20-11-04 |
1st Jan change | Capi. | |
---|---|---|
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |